- Filed
- Aug 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Aug 1, 2025 | 17.77M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 17.74K sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 12.42K sh |
| Shares Diluted restated | Q2 2025 · Jun 30, 2024 | 3.46K sh |
| Shares Diluted restated | Q2 2025 · Jun 30, 2024 | 3.43K sh |
| Capex | Q2 2025 · Jun 30, 2025 | $415K |
| Capex | Q2 2025 · Jun 30, 2024 | $474K |
| Operating Cash Flow | Q2 2025 · Jun 30, 2025 | −$30.49M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2024 | −$79.25M |
| Long Term Debt | Q2 2025 · Jun 30, 2025 | $94.81M |
| Long Term Debt | Q2 2025 · Dec 31, 2024 | $197.38M |
| Short Term Investments | Q2 2025 · Jun 30, 2025 | $144.53M |
| Short Term Investments | Q2 2025 · Dec 31, 2024 | $34.67M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2025 | $39.56M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $124.01M |
| Stockholders Equity | Q2 2025 · Jun 30, 2025 | $154.78M |
| Stockholders Equity | Q2 2025 · Mar 31, 2025 | $169.87M |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | $26.82M |
| Stockholders Equity | Q2 2025 · Jun 30, 2024 | $68.6M |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | $93.2M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $122.89M |
| Current Liabilities | Q2 2025 · Jun 30, 2025 | $36.91M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $45.38M |
| Total Liabilities | Q2 2025 · Jun 30, 2025 | $134.02M |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $248.98M |
| Current Assets | Q2 2025 · Jun 30, 2025 | $275.58M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $258.22M |
| Total Assets | Q2 2025 · Jun 30, 2025 | $288.8M |
| Total Assets | Q2 2025 · Dec 31, 2024 | $275.8M |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | −$1.04 |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | −$3.57 |
| Eps Diluted restated | Q2 2025 · Jun 30, 2024 | −$9.96 |
| Eps Diluted restated | Q2 2025 · Jun 30, 2024 | −$21.72 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | −$1.04 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | −$3.57 |
| Eps Basic restated | Q2 2025 · Jun 30, 2024 | −$9.96 |
| Eps Basic restated | Q2 2025 · Jun 30, 2024 | −$21.72 |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $9.16M |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $17.46M |
| Sga Expense | Q2 2025 · Jun 30, 2024 | $12.68M |
| Sga Expense | Q2 2025 · Jun 30, 2024 | $24.13M |
| Rd Expense | Q2 2025 · Jun 30, 2025 | $5.29M |
| Rd Expense | Q2 2025 · Jun 30, 2025 | $10.8M |
| Rd Expense | Q2 2025 · Jun 30, 2024 | $9.73M |
| Rd Expense | Q2 2025 · Jun 30, 2024 | $22.37M |
| Net Income | Q2 2025 · Jun 30, 2025 | −$18.54M |
| Net Income | Q2 2025 · Jun 30, 2025 | −$44.32M |
| Net Income | Q2 2025 · Mar 31, 2025 | −$25.78M |
| Net Income | Q2 2025 · Jun 30, 2024 | −$34.45M |
| Net Income | Q2 2025 · Jun 30, 2024 | −$74.4M |
| Net Income | Q2 2025 · Mar 31, 2024 | −$39.94M |
| Operating Income | Q2 2025 · Jun 30, 2025 | −$16.87M |
| Operating Income | Q2 2025 · Jun 30, 2025 | −$33.26M |
| Operating Income | Q2 2025 · Jun 30, 2024 | −$30.76M |
| Operating Income | Q2 2025 · Jun 30, 2024 | −$67.68M |
| Gross Profit | Q2 2025 · Jun 30, 2025 | $11.87M |
| Gross Profit | Q2 2025 · Jun 30, 2025 | $22.93M |
| Gross Profit | Q2 2025 · Jun 30, 2024 | $9.78M |
| Gross Profit | Q2 2025 · Jun 30, 2024 | $18M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2025 | $19.55M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2025 | $38.24M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2024 | $17.61M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2024 | $37.56M |
| Revenue | Q2 2025 · Jun 30, 2025 | $31.42M |
| Revenue | Q2 2025 · Jun 30, 2025 | $61.17M |
| Revenue | Q2 2025 · Jun 30, 2024 | $27.39M |
| Revenue | Q2 2025 · Jun 30, 2024 | $55.56M |